| 000 | 01889 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514220837.0 | ||
| 264 | 0 | _c20050607 | |
| 008 | 200506s 0 0 eng d | ||
| 022 | _a1078-0998 | ||
| 024 | 7 |
_a10.1097/01.mib.0000160770.94199.9b _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchaefer, Katherine L | |
| 245 | 0 | 0 |
_aIntestinal antiinflammatory effects of thiazolidenedione peroxisome proliferator-activated receptor-gamma ligands on T helper type 1 chemokine regulation include nontranscriptional control mechanisms. _h[electronic resource] |
| 260 |
_bInflammatory bowel diseases _cMar 2005 |
||
| 300 |
_a244-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aChemokine CXCL10 |
| 650 | 0 | 4 |
_aChemokines _xbiosynthesis |
| 650 | 0 | 4 | _aChemokines, CXC |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 | _aInflammation |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aNF-kappa B _xbiosynthesis |
| 650 | 0 | 4 |
_aPPAR gamma _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPioglitazone |
| 650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
| 650 | 0 | 4 |
_aT-Lymphocytes, Helper-Inducer _xdrug effects |
| 650 | 0 | 4 |
_aThiazolidinediones _xpharmacology |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 700 | 1 | _aDenevich, Svetlana | |
| 700 | 1 | _aMa, Chen | |
| 700 | 1 | _aCooley, Shane R | |
| 700 | 1 | _aNakajima, Atsushi | |
| 700 | 1 | _aWada, Koichiro | |
| 700 | 1 | _aSchlezinger, Jennifer | |
| 700 | 1 | _aSherr, David | |
| 700 | 1 | _aSaubermann, Lawrence J | |
| 773 | 0 |
_tInflammatory bowel diseases _gvol. 11 _gno. 3 _gp. 244-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.mib.0000160770.94199.9b _zAvailable from publisher's website |
| 999 |
_c15409726 _d15409726 |
||